These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24652456)

  • 1. Deregulation of brain insulin signaling in Alzheimer's disease.
    Chen Y; Deng Y; Zhang B; Gong CX
    Neurosci Bull; 2014 Apr; 30(2):282-94. PubMed ID: 24652456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.
    Chen Y; Zhang J; Zhang B; Gong CX
    Curr Top Med Chem; 2016; 16(5):485-92. PubMed ID: 26268336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
    Caccamo A; Belfiore R; Oddo S
    Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dark side of Alzheimer's disease: unstructured biology of proteins from the amyloid cascade signaling pathway.
    Gadhave K; Gehi BR; Kumar P; Xue B; Uversky VN; Giri R
    Cell Mol Life Sci; 2020 Oct; 77(20):4163-4208. PubMed ID: 31894361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
    Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
    Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
    Nguyen TT; Ta QTH; Nguyen TKO; Nguyen TTD; Giau VV
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice.
    Feng HL; Dang HZ; Fan H; Chen XP; Rao YX; Ren Y; Yang JD; Shi J; Wang PW; Tian JZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):734-741. PubMed ID: 27466310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies].
    Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D
    Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.
    Kwon OH; Cho YY; Kim TW; Chung S
    J Alzheimers Dis; 2019; 69(4):1195-1211. PubMed ID: 31156159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.
    Deng Y; Li B; Liu Y; Iqbal K; Grundke-Iqbal I; Gong CX
    Am J Pathol; 2009 Nov; 175(5):2089-98. PubMed ID: 19815707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis.
    Bloom GS; Lazo JS; Norambuena A
    Neuropharmacology; 2018 Jul; 136(Pt B):192-195. PubMed ID: 28965829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain insulin signaling and Alzheimer's disease: current evidence and future directions.
    Schiöth HB; Craft S; Brooks SJ; Frey WH; Benedict C
    Mol Neurobiol; 2012 Aug; 46(1):4-10. PubMed ID: 22205300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, neuroinflammation, and Alzheimer's disease.
    Najem D; Bamji-Mirza M; Chang N; Liu QY; Zhang W
    Rev Neurosci; 2014; 25(4):509-25. PubMed ID: 24622783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.
    Meeker KD; Meabon JS; Cook DG
    J Alzheimers Dis; 2015; 45(2):509-20. PubMed ID: 25589729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation Signaling in APP Processing in Alzheimer's Disease.
    Zhang T; Chen D; Lee TH
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
    Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.